Media coverage
7
Media coverage
Title Peer-Reviewed Study: bioAffinity Technologies’ CyPath® Lung Test Shows Potential Significant Healthcare Savings by Reducing Unnecessary Follow-Up, Medical Complications and Overdiagnosis Media name/outlet Business Wire Country/Territory United States Date 18/09/24 URL ct.moreover.com/?a=54813290005&p=1gw&v=1&x=yyg-oktIkiQn51U1nHNXjQ Persons Michael Morris Title Peer-Reviewed Study: bioAffinity Technologies’ CyPath® Lung Test Shows Potential Significant Healthcare Savings by Reducing Unnecessary Follow-Up, Medical Complications and Overdiagnosis Media name/outlet ADVFN UK Country/Territory United Kingdom Date 18/09/24 URL ct.moreover.com/?a=54813278319&p=1gw&v=1&x=3ckFkvqUV5ce-8HCB99anw Persons Michael Morris Title Peer-Reviewed Study: bioAffinity Technologies’ CyPath® Lung Test Shows Potential Significant Healthcare Savings by Reducing Unnecessary Follow-Up, Medical Complications and Overdiagnosis Media name/outlet StockTitan.net Country/Territory United States Date 18/09/24 URL ct.moreover.com/?a=54813297266&p=1gw&v=1&x=2bKlg7ZbnIxUAArH1vYh3w Persons Michael Morris Title Peer-Reviewed Study: bioAffinity Technologies’ CyPath® Lung Test Shows Potential Significant Healthcare Savings by Reducing Unnecessary Follow-Up, Medical Complications and Overdiagnosis Media name/outlet Yahoo! Finance Country/Territory United States Date 18/09/24 URL ct.moreover.com/?a=54813388576&p=1gw&v=1&x=m0nOOg3yFtNycNk3kIdTsw Persons Michael Morris Title Peer-Reviewed Study: bioAffinity Technologies’ CyPath® Lung Test Shows Potential Significant Healthcare Savings by Reducing Unnecessary Follow-Up, Medical Complications and Overdiagnosis Media name/outlet ADVFN US Country/Territory United States Date 18/09/24 URL ct.moreover.com/?a=54813294824&p=1gw&v=1&x=2E-Mut_Ybjbm3GjW9IuiyQ Persons Michael Morris Title Peer-Reviewed Study: bioAffinity Technologies' CyPath(TM) Lung Test Shows Potential Significant Healthcare Savings by Reducing Unnecessary Follow-Up, Medical Complications and Overdiagnosis Media name/outlet Stockwatch Country/Territory Canada Date 18/09/24 URL ct.moreover.com/?a=54813318887&p=1gw&v=1&x=4TsoPEFnJDaPeFBhMaZiBw Persons Michael Morris Title Peer-Reviewed Study: bioAffinity Technologies’ CyPath® Lung Test Shows Potential Significant Healthcare Savings by Reducing Unnecessary Follow-Up, Medical Complications and Overdiagnosis Media name/outlet BioSpace Country/Territory United States Date 18/09/24 URL ct.moreover.com/?a=54813620519&p=1gw&v=1&x=IfX789RFiFb1mBv-WgMWQg Persons Michael Morris